A newly configured federal vaccine panel's June 25 action is expected to improve options to protect infants from potentially deadly RSV.

ACIP Recommends Use of Merck’s ENFLONSIA™ (clesrovimab-cfor) for Prevention of Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Disease in Infants Younger than 8 Months of Age Born ...

I've tested all the latest and greatest Hall effect gaming keyboards and narrowed the competition down to the four best models available this weekend.

The trickle-down effect of President Trump's massive NIH budget cuts U.S. medical research is at a precipice as President Trump proposes cutting $18 billion from the National Institutes of Health.

GSK's regulatory filing for expanded use of RSV vaccine, Arexvy, in adults aged 18 years and older has been accepted for review by the EMA.

A U.S. government scientist who oversees the team responsible for collecting data on COVID-19 and RSV hospitalizations used to shape national vaccine policy has resigned, citing concerns over how ...

The Food and Drug Administration (FDA) expanded the approval of Moderna’s RSV vaccine late Thursday to include people 18 to 59 years old who are at increased risk for severe illness from ...